Month: December 2020
Kerja sama strategis ini memperluas jaringan pembayaran tunai ke 4.368 lokasi di pelosok negeri dan menjangkau seluruh lapisan masyarakatBUENA PARK, Calif., Dec. 17, 2020 (GLOBE NEWSWIRE) — Ria Money Transfer, perusahaan internasional terkemuka di bidang pengiriman uang lintas batas dan anak perusahaan Euronet Worldwide, Inc. (NASDAQ: EEFT), dan Pos Indonesia, perusahaan pos “pelat merah” Indonesia, hari ini mengumumkan kemitraan baru mereka untuk menyediakan layanan pembayaran tunai di seluruh Indonesia. Komunitas ekspatriat di Indonesia kini dapat mengirimkan uang secara aman kepada keluarga dan teman di luar negeri dari 4.368 cabang kantor pos di seluruh Indonesia.Kerja sama ini merupakan perwujudan strategi ekspansi menyeluruh yang diterapkan Ria melalui jaringan layanan posnya. Perjanjian kemitraan ini merupakan tonggak bersejarah...
ScION Tech Growth I Announces Pricing of $500 Million Initial Public Offering
Written by Customer Service on . Posted in Public Companies.
LONDON, UNITED KINGDOM, Dec. 16, 2020 (GLOBE NEWSWIRE) — ScION Tech Growth I (“ScION” or the “Company”) announced today the pricing of its initial public offering of 50,000,000 units at $10.00 per unit. The units will be listed on the Nasdaq Capital Market (“Nasdaq”) under the symbol “SCOAU” and will begin trading on December 17, 2020. Each unit consists of one of the Company’s Class A ordinary shares and one-third of one warrant, each whole warrant entitling the holder thereof to purchase one of the Company’s Class A ordinary shares at an exercise price of $11.50 per share. Only whole warrants are exercisable. Once the securities constituting the units begin separate trading, we expect that the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “SCOA” and “SCOAW”, respectively.ScION is a...
Pure Extracts Technologies Corp. Announces Special Warrant Offering
Written by Customer Service on . Posted in Public Companies.
Not for distribution to United States newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, in or into the United States.VANCOUVER, British Columbia, Dec. 16, 2020 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (“Pure” or the “Company”) (CSE: PULL) (XFRA: A2QJAJ), a plant-based extraction company, is pleased to announce that it intends to raise up to $4,000,000 via a non-brokered private placement offering (the “Offering”) of special warrants (each, a “Special Warrant”) at a price of $0.505 per Special Warrant. The Special Warrants will automatically convert to units (the “Units”) upon the earlier of the receipt for a final prospectus qualifying the distribution of the Units or four months and a day from the final closing date of the Offering. Each Unit will...
Algernon CEO and CSO to Discuss COVID-19 Interim Data Results Featured on BioPub Webcast Hosted by Dr. KSS MD PhD
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Dec. 16, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”), a clinical stage pharmaceutical development company, is pleased to announce that Algernon’s CEO Christopher J. Moreau and CSO Dr. Mark Williams, will be discussing the Company’s interim data report for the Company’s Phase 2b/3 clinical study of Ifenprodil for COVID-19 on an upcoming BioPub webcast.The BioPub webcast will be held Thursday December 17, 2020 hosted by Dr. KSS at noon EDT. The Company invites interested shareholders, investors, members of the media and the public to listen to the interview free of charge.BioPub has been analyzing small-cap special situation biotech investments for seven years to readers in over 40 countries.
BioPub.co Discussing Ifenprodil...
Cenovus and Husky announce Court of Queen’s Bench approval of proposed business combination
Written by Customer Service on . Posted in Public Companies.
CALGARY, Alberta, Dec. 16, 2020 (GLOBE NEWSWIRE) — Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) and Husky Energy Inc. (TSX: HSE) are pleased to announce the Court of Queen’s Bench of Alberta has issued a final order approving the previously announced Plan of Arrangement to combine the two companies. The court’s approval follows separate votes held on December 15, 2020 in which Cenovus common shareholders and Husky common shareholders, optionholders and preferred shareholders supported the proposed transaction to combine the two companies into a resilient integrated energy leader.Closing of the transaction remains subject to the receipt of all necessary regulatory approvals and to other customary closing conditions.ADVISORYThis news release contains certain forward-looking statements and forward-looking information (collectively referred...
Cenovus and Husky announce Court of Queen’s Bench approval of proposed business combination
Written by Customer Service on . Posted in Public Companies.
CALGARY, Alberta, Dec. 16, 2020 (GLOBE NEWSWIRE) — Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) and Husky Energy Inc. (TSX: HSE) are pleased to announce the Court of Queen’s Bench of Alberta has issued a final order approving the previously announced Plan of Arrangement to combine the two companies. The court’s approval follows separate votes held on December 15, 2020 in which Cenovus common shareholders and Husky common shareholders, optionholders and preferred shareholders supported the proposed transaction to combine the two companies into a resilient integrated energy leader.Closing of the transaction remains subject to the receipt of all necessary regulatory approvals and to other customary closing conditions.ADVISORYThis news release contains certain forward-looking statements and forward-looking information (collectively referred...
Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 Vaccine
Written by Customer Service on . Posted in Public Companies.
GAITHERSBURG, Md., Dec. 16, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced an Advance Purchase Agreement with the government of New Zealand for the purchase of 10.7 million doses of NVX-CoV2373, Novavax’ candidate vaccine against COVID-19.Currently in Phase 3 clinical testing in the United Kingdom for the prevention of COVID-19, NVX-CoV2373 is a recombinant protein vaccine adjuvanted with Novavax’ proprietary Matrix-M™ to enhance the immune response.“The global reach of the pandemic requires that all regions of the world have an adequate supply of vaccine available to protect their entire citizenry,” said Stanley C. Erck, President and Chief Executive Officer of Novavax. “We appreciate the confidence of...
Eloro Resources Announces Filing of Preliminary Short Form Prospectus
Written by Customer Service on . Posted in Public Companies.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.TORONTO, Dec. 16, 2020 (GLOBE NEWSWIRE) — Eloro Resources Ltd. (the “Company” or “Eloro”) (TSX-V: ELO; OTCQX: ELRRF; FSE: P2QM) is pleased to announce that, in connection with its previously announced bought deal financing (see Eloro press releases dated December 9, 2020), it has filed a preliminary short form prospectus with the applicable securities regulators in each of the provinces of Canada, except Quebec. Under the terms of the financing, Haywood Securities Inc., as lead underwriter, and Echelon Wealth Partners Inc. (the “Underwriters”) have agreed to purchase, on a bought deal basis, 3,548,400 units (the “Units”) at a price of Cdn$1.55 per Unit...
Phathom Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Written by Customer Service on . Posted in Public Companies.
FLORHAM PARK, N.J., Dec. 16, 2020 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today the pricing of its underwritten public offering of 2,250,000 shares of its common stock at a price to the public of $42.00 per share. All of the shares to be sold in the offering are being sold by Phathom. The gross proceeds to Phathom from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be $94.5 million. In addition, Phathom has granted the underwriters a 30-day option to purchase up to an additional 337,500 shares of common stock at the public offering price, less underwriting discounts and commissions. The offering...
Pandemic Accelerates Australia’s Broad Move Toward Cloud Computing, Digital Transformation
Written by Customer Service on . Posted in Public Companies.
SYDNEY, Australia, Dec. 16, 2020 (GLOBE NEWSWIRE) — Many Australian companies are joining a broad movement in the country toward cloud computing and digital transformation, a trend accelerated by the COVID-19 crisis, according to a new report published today by Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm.The 2020 ISG Provider Lens™ Digital Business – Solutions and Service Partners report for Australia, the first such ISG report focusing on the country’s digital business provider ecosystem, finds many Australian enterprises looking for digital ways to be more competitive, improve supply chains, enable remote working and ensure business continuity. These goals became even more urgent with the arrival of the pandemic, which severely disrupted business practices even though...
